8.2 Noncontrolled Prescription Form and Content
Key Takeaways
- CGS § 20-614(a) allows a prescription to be transmitted orally, in writing, or electronically to a pharmacy.
- For oral or electronic noncontrolled prescriptions, CGS § 20-614(b) requires a pharmacist or pharmacy intern to record the order on a prescription form or electronic record not later than the end of the business day it was received.
- Required recorded elements include the prescriber's name and address; date; drug name, dosage form, strength where applicable, and amount; patient name and address (or veterinary owner and species); directions; required cautionary statements; and refill quantity, including PRN or ad lib.
- A written prescription must also bear the practitioner's written signature or satisfy CGS § 19a-509c, and no written Schedule II blank may contain an order for any other legend drug or device (CGS § 20-614(c)).
- CGS § 20-614 also requires an offer for the pharmacist to discuss and counsel on the drug being dispensed; the full counseling rules are in Chapter 11.
Why form and content are tested separately from controlled substances
Quick Answer: CGS § 20-614 is the Pharmacy Practice Act rule for how a prescription is transmitted and recorded. A prescription may be oral, written, or electronic. For noncontrolled oral or electronic orders, a pharmacist or pharmacy intern must record the prescription not later than the end of the business day it was received. The record must include the prescriber, date, drug (name, dosage form, strength where applicable, amount), patient (or veterinary owner and species), directions, cautionary statements, and refills (including PRN or ad lib). Written blanks also need a signature (or CGS § 19a-509c). Offer to counsel lives in the same statute; details are Chapter 11. Controlled-substance extras are CGS § 21a-249 (section 8.3).
NABP Competency 2.1.3 is the noncontrolled issuance leaf. Connecticut's answer is almost entirely § 20-614. Do not import DEA numbers, adult/child flags, or the EPCS mandate into a lisinopril oral order. Those are Chapter 420b rules. Do not skip patient address or veterinary species because “everyone in town knows the dog.” The statute lists the data elements.
Three lawful ways to send a prescription
CGS § 20-614(a) is one sentence: a prescription shall be transmitted in either an oral, written, or electronic manner to a pharmacy. That is the entire transmission menu for legend drugs. A text message to the technician's personal phone, a sticky note on the drive-through window, or a caregiver's recollection with no prescriber contact is not a prescription.
Electronic data intermediaries (entities that connect prescriber systems to pharmacy systems) may transfer electronic prescription data to a pharmacy of the patient's choice, licensed in Connecticut or in another U.S. state or territory. They may not alter transmitted data except as needed for technical processing. They need Commissioner of Consumer Protection approval. That is the legal home of Surescripts-style routing, not a second way to skip a prescriber.
Oral and electronic noncontrolled orders — same-day record
CGS § 20-614(b) applies whenever a pharmacy, or an institutional pharmacy in a hospital that is dispensing for outpatient use or for a hospital employee (or the employee's spouse or dependent children), receives an oral or electronically transmitted prescription except for a controlled drug as defined in CGS § 21a-240. Controlled drugs follow § 21a-249, not this same-day noncontrolled record rule.
A record of that noncontrolled prescription shall be maintained in writing or electronically. The pharmacist or pharmacy intern shall, not later than the end of the business day when the prescription was received, record it on a prescription form or in an electronic record including all of the following:
- Name and address of the prescribing practitioner
- Date of the prescription
- Name, dosage form, strength where applicable, and amount of the drug prescribed
- Name and address of the patient, or for veterinary prescriptions the name and address of the owner and the species of the animal
- Directions for use
- Any required cautionary statements
- The number of times the prescription may be refilled, including the refill terms “PRN” and “ad lib” in lieu of a specific number
Two personnel traps sit in that sentence. Technicians may not take new verbal orders (RCSA § 20-576-39; Chapter 4). Interns may. The recorder is a pharmacist or intern, not “anyone with a headset.” And the clock is end of that business day, not “when we get a chance this week” and not the federal CS emergency covering-prescription clock. If the oral amoxicillin arrives at 4:50 p.m. and the pharmacy closes at 6:00 p.m., the record is due that evening, not tomorrow morning's opening huddle.
PRN and ad lib are expressly lawful noncontrolled refill terms under § 20-614. They are not a way to write “refill forever” on a benzodiazepine. Controlled-substance refill caps are Chapter 9 and § 21a-249(h).
Written prescriptions — signature plus the same core data
CGS § 20-614(c) lists what a written prescription shall bear:
| Element | Oral/electronic non-CS record (§ 20-614(b)) | Written prescription (§ 20-614(c)) |
|---|---|---|
| Prescriber identity | Name and address | Written signature of the practitioner or compliance with CGS § 19a-509c, plus the practitioner's address |
| Date | Date of the prescription | Date of the prescription |
| Drug | Name, dosage form, strength where applicable, amount | Name, dosage form, strength where applicable, amount |
| Patient | Name and address; or owner name/address and species | Same |
| Directions | Directions for use | Directions for use |
| Warnings | Required cautionary statements | Required cautionary statements |
| Refills | Number, or PRN / ad lib | Number, or PRN / ad lib |
| Extra written CII rule | (CS rules are in § 21a-249) | No written Schedule II form may contain an order for any other legend drug or device |
The written-CII-alone rule in § 20-614(c) is the Pharmacy Practice Act version of the one-controlled-substance-per-blank rule you will see again in § 21a-249(a). A paper blank that pairs oxycodone with ibuprofen is already a § 20-614 problem even before you reach EPCS.
CGS § 19a-509c is the alternative to a wet signature that the written-prescription subsection names. Do not invent a Connecticut “stamp signature” or rubber-nameplate practice; § 21a-249 will separately reject rubber-stamped controlled orders. If the stem is a community paper prescription for metformin, look for the practitioner's written signature and address.
Missing patient address is a classic fail. “Take one daily” without a strength when multiple strengths exist is a fail. A veterinary phenobarbital order (noncontrolled in some formulations; the form rule is the same) that names “Buddy” but not the owner or the species is a fail.
Offer to consult — teaser only
The current catchline of § 20-614 is “Prescriptions: Form and content. Offer to consult with pharmacist.” Current subsection language requires that, prior to or simultaneous with dispensing, a pharmacist or other pharmacy employee shall, whenever practicable, offer for the pharmacist to discuss the drug to be dispensed and counsel the patient on usage, except when the person picking up is not the person named on the prescription or the pharmacist determines a written offer is appropriate. A written offer must include an offer to communicate in person at the pharmacy or by telephone. Nothing in the section requires counseling of a patient who refuses. The pharmacist keeps a record of counseling, refusal, or inability to accept counseling. Chapter 11 is the counseling, HIPAA, and refusal-documentation chapter. Here, know that the offer is statutory, it is tied to dispensing, and it is not optional because the store is busy.
Realistic Connecticut scenarios
A Waterbury intern takes a new oral order for atorvastatin 40 mg, #90, one daily, two refills, for an adult patient whose address is already in the profile. The intern is still on the phone at 5:40 p.m. in a pharmacy that closes at 6:00 p.m. § 20-614(b) is satisfied only if that intern (or a pharmacist) records every listed element before the business day ends. Leaving a sticky note that says “call Dr. Lee back tomorrow to finish the address” is not a completed record.
A technician accepts a new verbal order for sertraline because “the pharmacist is on lunch in the building.” That is a technician limitation (Chapter 4) layered on § 20-614. The recorder must be a pharmacist or intern.
A Danbury veterinarian phones in cephalexin for a golden retriever. The intern records the drug, strength, and SIG but only the animal's name. § 20-614(b)(4) wants the owner's name and address and the species. “Golden retriever, owner Jane Doe, 12 Main Street” is the record; “Buddy” is not.
A paper prescription arrives with lisinopril 10 mg and, on the same blank, a Schedule II oxycodone order. Even if EPCS were not in the picture, § 20-614(c) forbids any other legend drug or device on a written Schedule II form. Do not fill the pair as written. Section 8.3 then asks whether the CII should have been electronic in the first place.
A caregiver picks up amlodipine for her father. The offer-to-counsel rule still exists, but the statute expressly contemplates that the person obtaining the drug may not be the named patient; a written offer that includes in-person or telephone counseling is the path. Do not skip the offer because “it's a refill she has taken for years.” Chapter 11 works the counseling mechanics; this chapter only flags that § 20-614 is where the offer lives.
Connecticut may add documentation or counseling expectations on top of OBRA '90. CT may be stricter; more-restrictive wins.
Official anchors
- CGS Chapter 400j — § 20-614 (form and content; offer to consult; electronic data intermediaries) and § 20-571 (prescription and prescribing-practitioner definitions).
- CGS § 20-614 — oral/written/electronic transmission; end-of-business-day recording by pharmacist or intern; written elements; CII-alone-on-the-blank rule.
A Connecticut community pharmacy receives a new oral prescription for noncontrolled lisinopril at 4:45 p.m. and closes at 6:00 p.m. Under CGS § 20-614(b), who must record the order and by when?
Which set of elements must appear when a pharmacist or intern records an oral noncontrolled prescription under CGS § 20-614(b)?
A written Connecticut prescription form contains both oxycodone 5 mg (Schedule II) and ibuprofen 600 mg. Which statement is correct under CGS § 20-614(c)?